13/01/2024 Appellate Judgment of the Ho Chi Minh City People’s Court regarding the dispute over a goods sale and purchase contract between DBD and Dong Nam
30/10/2023 Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements Compared to the Same Period in 2022
21/08/2023 Report on Change in Ownership of Major Shareholders and Investors Holding 5% or More of Closed-End Fund Certificates
04/08/2023 List of Related Persons of the Company in the Semi-Annual Corporate Governance Report 2023, No. 858/BC-DBD dated July 29, 2023
25/07/2023 Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements for the Second Quarter of 2023 Compared to the Same Period in 2022
17/07/2023 Resolution of the Board of Directors No. 814/NQ-HĐQT dated July 17, 2023 on the Selection of the Auditing Firm for 2023
30/06/2023 Resolution of the Board of Directors No. 736/NQ-DBD-HĐQT dated June 30, 2023 on the Implementation of the Investment in a Small-Volume Parenteral Drug Manufacturing Plant
06/05/2023 Corporate Governance Regulations of Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) – 2023
26/10/2022 Explanation of the difference of 10% or more in NPAT of the 3rd quarter consolidated financial statements of the third quarter of 2022 compared to the same period last year
